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Abstract
Reduced absorption capacity in patients with intestinal resections (IR) could result in malabsorption of fat-soluble components like carotenoids, which are
of clinical interest in relation to visual health. In this case cohort, we investigated the association between IR and serum lutein, zeaxanthin, β-carotene and
macular pigment optical density, when compared with healthy controls. Ten patients with IR and twelve healthy controls were included in the study.
Baseline characteristics were comparable between groups, except for higher serum TAG (P< 0·05) and shorter bowel length (P < 0·0001) in the group
with IR. Serum lutein, zeaxanthin, β-carotene and macular pigment optical density were >15 % lower in the patient group compared with healthy controls
(P< 0·05, adjusted for age) and, in the case of serum lutein and zeaxanthin, also for dietary intake of carotenoids. Results suggest that for a test of macular
carotenoid supplementation, subjects with a potentially clinically signiﬁcant carotenoid deﬁcit could be recruited among patients with IR.
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Levels of the macular xanthophylls lutein, zeaxanthin and meso-
zeaxanthin have been associated with slower progression of
age-related macular degeneration(1), potentially through their
action in quenching reactive oxygen species, scavenging blue
light and thereby protecting the eye from photo-oxidative dam-
age(2). Carotenoids are not synthesised de novo in humans(3) and
we therefore depend on dietary intake and efﬁcacy of absorp-
tion for their action. Reduced absorption capacity in the small
bowel secondary to surgical resection could thereby put these
patients at risk for malabsorption of carotenoids relevant for
visual health. In addition, underlying conditions, which inﬂu-
ence intestinal mucosa integrity, transport capacity, availability
of lipids for carotenoid solubilisation and gastric passage time,
are expected to be important parameters for carotenoid absorp-
tion capacity(4). The severity of malabsorption is expected to
reﬂect among other underlying diseases, area of resection,
length, and health of the remaining tissue(5). There is little scien-
tiﬁc information, however, about serum levels of non-essential
fat-soluble components such as carotenoids and their clinical
correlates in patients with altered gut absorption.
The aim of the present study was, through exploratory mea-
sures, to investigate levels of serum carotenoids and optical
density of the macular pigment in a case cohort of patients
with intestinal resection and healthy subjects.
Abbreviation: MPOD, macular pigment optical density.
*Corresponding author: J. N. Eriksen, email j-n-e@nexs.ku.dk
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Subjects and methods
Subjects and study design
The recruitment methodology is described in detail in the
study by JN Eriksen et al. (unpublished results) and in the
Supplementary material. In brief, we recruited twelve healthy
subjects and ten patients with intestinal resections (140–350
cm small intestine left) from a pool of volunteers and from
the Department of Gastroenterology of the Rigshospitalet,
respectively, to participate in a cross-over study of carotenoid
supplementation. The data presented here are from the baseline
examination. Subjects were matched by age (±5 years) and sex.
Ethical approval
The study was approved by The Danish National Committee
on Health Research Ethics (study no. H-3-2014-112) and
registered at clinicaltrial.gov (study no. NCT02450227).
Carotenoid dietary intake
Intake of lutein and zeaxanthin was calculated as crude esti-
mates (lutein/zeaxanthin score) and categorised into three
groups using a lutein/zeaxanthin screening tool based on
intake and relative bioavailability in four food groups (eggs,
broccoli, maize, and dark leafy vegetables)(6).
Blood sampling, carotenoid extraction and quantification
Methodologies for blood sampling, carotenoid extraction and
quantiﬁcation have been described by Eriksen et al.(7).
Vision study
Macular pigment optical density (MPOD) was assessed from
blue light autoﬂuorescence (BAF) fundus images from both
eyes of each subject and analysed using Corel Paint Shop
Pro (Corel Corporation). BAF images and optical coherence
tomography scans of the retina and structures of the posterior
pole of the eye were obtained by scanning laser ophthalmo-
scope (Heidelberg Spectralis HRA; Heidelberg Engineering
GmbH). MPOD was calculated as the density of the fovea
relative to the average of two reference areas on the nasal
and temporal side of the foveal zone of xanthophyll
pigmentation.
Data analysis
Data processing and statistical analysis were conducted in
GraphPad Prism version 6.03 (GraphPad Software Inc.,
2013) and R version 3.1.1. (R Core Team, 2013).
Continuous variables were checked by the Shapiro–Wilk test
for normality. For differences between baseline variables in
the two groups, Student’s t test, the Mann–Whitney non-
parametric test and Fisher’s exact test were applied. Linear
regression models were constructed to test for association
between the dependent variables lutein, zeaxanthin,
β-carotene and MPOD, and the independent variables bowel
length or study group (healthy/intestinal resection). Multiple
linear regression models were applied to adjust for confound-
ing variables found to be associated with the dependent vari-
able or if a physiological relationship was found established in
the literature. Age was always included in the adjustment.
Table 1. Baseline covariates in the two study groups
(Mean values and standard deviations; percentages; medians and ranges; numbers of subjects)
Intestinal resection (n 10) Healthy (n 12)
Mean SD Mean SD P
Age (years) 50·2 10·1 49·6 8·2 0·519†
Sex, female (%) 60 67 1·000
BMI (kg/m2) 25·2 2·5 24·3 2·5 0·742†
Bowel length (cm) <0·0001****§
Median 330 650‡
Range 140–350
Serum (mmol/l)ǁ
TAG 0·015*§
Median 1·75 0·72
Range 0·65–7·07 0·51–1·36
Cholesterol 0·589§
Median 4·71 4·59
Range 3·39–6·78 3·65–5·64
Fasting blood sugar (mmol/l) 5·30 0·25 5·11 0·42 0·136†
Lutein/zeaxanthin score¶ (n)ǁ
1 5 9 0·331††
2 4 2
3 0 1
* P < 0·05, **** P < 0·0001.
† Student’s t test.
‡ Theoretical value.
§ Mann–Whitney non-parametric test.
ǁ n 9 for intestinal resection group.
¶ Score calculated based on intake and relative bioavailability in four food groups.
†† Fisher’s exact test.
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Results and discussion
The two study groups, patients with intestinal resection and
healthy subjects, were of comparable age and sex distribution
(Table 1). The patients with intestinal resection had roughly
half the bowel length (140–350 cm, comprising jejunostomy
and ileostomy, P< 0·0001) and twice the serum TAG level
(P< 0·05) of the healthy subjects. Patients with intestinal
resection were the result of surgical resection for ulcerative col-
itis (n 1), Crohn’s disease (n 8) and radiation enteropathy (n 1).
All patients with intestinal resection used oral vitamin supple-
ments and two received intravenous ﬂuid therapy.
Differences in serum lutein, zeaxanthin and β-carotene
between the two groups are presented in Tables 2 and 3.
Circulating levels of carotenoids are expected to reﬂect carot-
enoid intake, bioavailability and here also absorption capacity.
The three carotenoids lutein, zeaxanthin and β-carotene were
higher (P < 0·05) in healthy subjects than in patients with
intestinal resection (P< 0·05, adjusted for age and, in the
case of lutein and zeaxanthin, for dietary intake of these two
carotenoids). Serum carotenoids and MPOD were also
found associated with the continuous variable bowel length
(data not presented). The mean (or median) serum concentra-
tions of lutein, zeaxanthin and β-carotene were 0·165, 0·034
and 0·493 µmol/l, respectively, in healthy subjects and
0·115, 0·027 and 0·111, respectively, in patients with intestinal
resection (Table 2). Comparable studies in patients with intes-
tinal resection are to our knowledge limited to studies investi-
gating the relationship with underlying disease including
ulcerative colitis(8) and Crohn’s disease(9).
Serum carotenoids may affect visual health in several ways.
β-Carotene is associated with visual health through its role as a
pro-vitamin A carotenoid, whereas lutein and zeaxanthin are
Table 2. Baseline characteristics of study participants
(Mean values and standard deviations; medians and interquartile ranges)
Intestinal resection (n 10) Healthy (n 12)
Mean SD Mean SD P
Serum carotenoids (μmol/l)
Lutein 0·115 0·078 0·165 0·053 0·092†
Zeaxanthin 0·099‡
Median 0·027 0·034
Interquartile range 0·001–0·038 0·027–0·044
β-Carotene 0·022*‡
Median 0·111 0·493
Interquartile range 0·001–0·420 0·0395–0·624
Macular pigment optical density 0·506 0·113 0·606 0·098 0·043*†
* P < 0·05.
† Student’s t test.
‡Mann–Whitney test.
Table 3. Cross-sectional associations for difference in serum carotenoids (μmol/l) and macular pigment optical density between short-bowel patients and
age (± 5 years)- and sex-matched controls
(β-Coefficients and standard errors)
Unadjusted Adjusted
β SE P β SE P
Serum lutein (μmol/l)
Group difference 0·0502 0·0283 0·0923 0·0618 0·0267 0·0341*
Full age adjustments† −0·0035 0·0015 0·0303*
Lutein/zeaxanthin score adjustments – – –
2 0·0537 0·0293 0·0857
3 0·0226 0·0608 0·7156
Serum zeaxanthin (μmol/l)
Group difference 0·0112 0·0066 0·1069 0·0138 0·0061 0·0382*
Full age adjustments −0·0008 0·0003 0·0320*
Lutein/zeaxanthin score – – –
2 0·0126 0·0067 0·0788
3 0·0069 0·0139 0·6291
Serum β-carotene (μmol/l)
Group difference 0·1924 0·0882 0·0421* 0·1879 0·0789 0·0284*
Full age adjustments −0·0106 0·0044 0·0268*
Macular pigment optical density
Group difference 0·0999 0·0001 0·0125* 0·1029 0·0395 0·0181*
Full age adjustments −0·0064 0·0023 0·0188*
* P < 0·05.
† Age-matching was performed in a broad interval and these adjustments correct for residual age differences arising from unequal group size.
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found as pigments in the macula lutea. MPOD levels were sig-
niﬁcantly lower in patients with intestinal resection compared
with healthy controls (Tables 2 and 3; P< 0·05).
Comparable studies have to our knowledge not been pub-
lished at the present time and evidence on visual complications
secondary to malabsorption of vitamin A and carotenoids in
related patient groups is limited to a few case studies(10,11).
Supporting evidence can, however, be found in publications
investigating serum carotenoid levels, MPOD and objective
measures of visual function in cystic ﬁbrosis patients. It has
been suggested that absorption of carotenoids in this patient
group could be hampered by pancreatic insufﬁciency not
fully substituted by enzyme replacement therapy. Two small
studies with nine and ten cystic ﬁbrosis patients showed
lower serum carotenoids and lower MPOD, but did not ﬁnd
a signiﬁcant effect on visual acuity(12,13). Evidence is, however,
still lacking for the effect of long-term decrease in macula pig-
ments and the risk of later visual complications.
The present study is limited in sample size and inter-
correlation between absorption capacity, serum levels, and
the functional markers of vision, MPOD, makes analyses chal-
lenging. Future studies should focus on the physiological effect
of reduced circulating carotenoid levels on MPOD in patient
groups with malabsorption, potentially with additional mea-
surements of other fat-soluble vitamins.
Conclusion
The present study found lower serum carotenoids and lower
macular pigment optical densities in patients with intestinal
resection than in healthy subjects. While there is no certain
knowledge about the effects of having low serum carotenoid
levels, there are important indications that low retinal caroten-
oid levels may have a deleterious effect on retinal health. Our
ﬁndings suggest that patients with intestinal resection or even
short bowel disease should be examined, in a scientiﬁc context,
for signs of poor retinal health. Our results should be validated
in larger studies.
Supplementary material
The supplementary material for this article can be found at
https://doi.org/10.1017/jns.2017.71
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